NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT05377996 2025-10-28A Study of XMT-1660 in Participants With Solid TumorsMersana TherapeuticsPhase 1 Recruiting319 enrolled
NCT03680560 2020-03-31Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor CancersCogent Biosciences, Inc.Phase 1 Terminated6 enrolled